ENTA Competitors & Alternatives
Compare Enanta Pharmaceuticals Inc with similar stocks in the same industry
Biotechnology
ENTA
Main Stock$10.79
-1.82%
Tradestie Score
46
Market Cap
$226.82M
Revenue Growth
-21.6%
Analyst Upside
+102.3%
Supply-Chain & Ecosystem Map (Customers, Suppliers & Direct Competitors)
Bottleneck Score: 2/10
Drug Discovery Biotech
Drug Design
Top Competitors
217 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CAPR
Capricor Therapeutics Inc
|
$8.45
-11.39%
|
$357.51M | - | 28 | Compare |
|
DMAC
DiaMedica Therapeutics Inc. Common Stock
|
$8.39
-4.55%
|
$354.59M | - | 48 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$9.65
-6.13%
|
$354.45M | - | 47 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$43.04
+0.07%
|
$353.70M | - | 36 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$3.63
-7.53%
|
$332.96M | - | 46 | Compare |
|
REPL
Replimune Group, Inc.
|
$21.56
-1.51%
|
$328.62M | - | 26 | Compare |
|
EPRX
Eupraxia Pharmaceuticals Inc. Common Stock
|
$7.54
-7.48%
|
$307.12M | - | 32 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$6.09
-1.85%
|
$304.12M | - | 47 | Compare |
|
JBIO
Jade Biosciences, Inc. Common Stock
|
$15.52
-3.87%
|
$297.23M | - | 36 | Compare |
|
OMER
Omeros Corporation
|
$17.18
-1.80%
|
$281.75M | 14.9 | 55 | Compare |
More ENTA Analysis
Data updated: Nov 16, 2026 | Industry: Biotechnology (SIC 2834)
217 stocks in this industry